-
1
-
-
0026425587
-
Antitumor activity of UCN-01, a selective inhibitor of protein kinase C, in marine and human tumor models
-
1. Akinaga S, Gomi K, Morimoto M, Tamaoki T, Okabe M (1991) Antitumor activity of UCN-01, a selective inhibitor of protein kinase C, in marine and human tumor models. Cancer Res 51: 4888
-
(1991)
Cancer Res
, vol.51
, pp. 4888
-
-
Akinaga, S.1
Gomi, K.2
Morimoto, M.3
Tamaoki, T.4
Okabe, M.5
-
4
-
-
0021118703
-
Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors
-
4. Chou T-C, Talalay P (1984) Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22: 27
-
(1984)
Adv Enzyme Regul
, vol.22
, pp. 27
-
-
Chou, T.-C.1
Talalay, P.2
-
5
-
-
0030055094
-
Current perspectives on camptothecins in cancer treatment
-
5. Dancey J, Eisenhauer EA (1996) Current perspectives on camptothecins in cancer treatment. Br J Cancer 74: 327
-
(1996)
Br J Cancer
, vol.74
, pp. 327
-
-
Dancey, J.1
Eisenhauer, E.A.2
-
6
-
-
0025133118
-
Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons
-
6. D'Apra P, Beardmore C, Liu LF (1990) Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons. Cancer Res 50: 6919
-
(1990)
Cancer Res
, vol.50
, pp. 6919
-
-
D'Apra, P.1
Beardmore, C.2
Liu, L.F.3
-
7
-
-
0025912568
-
Synergistic cytotoxic actions of cisplatin and liposomal valinomycin on human ovarian carcinoma cells
-
7. Daoud SS, Forde NH (1991) Synergistic cytotoxic actions of cisplatin and liposomal valinomycin on human ovarian carcinoma cells. Cancer Chemother Pharmacol 28: 370
-
(1991)
Cancer Chemother Pharmacol
, vol.28
, pp. 370
-
-
Daoud, S.S.1
Forde, N.H.2
-
8
-
-
0024324836
-
Modulation of doxorubicin resistance by valinomycin (NSC 122023) and liposomal valinomycin in Chinese hamster ovary cells
-
8. Daoud SS, Juliano RL (1989) Modulation of doxorubicin resistance by valinomycin (NSC 122023) and liposomal valinomycin in Chinese hamster ovary cells. Cancer Res 49: 2661
-
(1989)
Cancer Res
, vol.49
, pp. 2661
-
-
Daoud, S.S.1
Juliano, R.L.2
-
9
-
-
0030465772
-
The cell cycle effects of camptothecins
-
Pantazis P, Giovanella BC, Rothenberg ML (eds). New York Academy of Sciences, New York
-
9. Darzynkiewicz Z, Bruno S, Del Bino G, Traganos F (1996) The cell cycle effects of camptothecins. In: Pantazis P, Giovanella BC, Rothenberg ML (eds) The camptothecins from discovery to the patient, vol 803. New York Academy of Sciences, New York, p 93
-
(1996)
The Camptothecins from Discovery to the Patient
, vol.803
, pp. 93
-
-
Darzynkiewicz, Z.1
Bruno, S.2
Del Bino, G.3
Traganos, F.4
-
10
-
-
0029036445
-
The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemia cells to topoisomerase I and II inhibitors
-
10. Dubrez L, Goldwasser F, Genne P, Pommier Y, Solary E (1995) The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemia cells to topoisomerase I and II inhibitors. Leukemia 9: 1013
-
(1995)
Leukemia
, vol.9
, pp. 1013
-
-
Dubrez, L.1
Goldwasser, F.2
Genne, P.3
Pommier, Y.4
Solary, E.5
-
11
-
-
0028171454
-
p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents
-
11. Fan S, El-Deiry WS, Bae I, Freeman J, Jondle D, Bhatia K, Forance AJ, Magrath I, Kohn KW, O'Connor PM (1994) p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res 54: 5824
-
(1994)
Cancer Res
, vol.54
, pp. 5824
-
-
Fan, S.1
El-Deiry, W.S.2
Bae, I.3
Freeman, J.4
Jondle, D.5
Bhatia, K.6
Forance, A.J.7
Magrath, I.8
Kohn, K.W.9
O'Connor, P.M.10
-
12
-
-
0028901034
-
Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline
-
12. Fan S, Smith LM, Rivett, JD, Duba D, Zhan Q, Kohn WK, Fornace JA, O'Connor MP (1995) Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. Cancer Res 55: 1649
-
(1995)
Cancer Res
, vol.55
, pp. 1649
-
-
Fan, S.1
Smith, L.M.2
Rivett, J.D.3
Duba, D.4
Zhan, Q.5
Kohn, W.K.6
Fornace, J.A.7
O'Connor, M.P.8
-
14
-
-
0030844899
-
Sensitivity to camptothecin of human breast cancer cells and normal bovine endothelial cells, in vitro
-
14. Jones CB, Clements MK, Wasi S, Daoud SS (1997) Sensitivity to camptothecin of human breast cancer cells and normal bovine endothelial cells, in vitro. Cancer Chemother Pharmacol 40: 475
-
(1997)
Cancer Chemother Pharmacol
, vol.40
, pp. 475
-
-
Jones, C.B.1
Clements, M.K.2
Wasi, S.3
Daoud, S.S.4
-
15
-
-
9844267069
-
Synergy between UCN-01 and camptothecin-induced cytotoxicity in breast cancer cells
-
15. Jones CB, Clements MK, Wasi S, Daoud SS (1997) Synergy between UCN-01 and camptothecin-induced cytotoxicity in breast cancer cells. Proc Am Assoc Cancer Res 38: 102
-
(1997)
Proc Am Assoc Cancer Res
, vol.38
, pp. 102
-
-
Jones, C.B.1
Clements, M.K.2
Wasi, S.3
Daoud, S.S.4
-
16
-
-
0024425887
-
Checkpoints: Controls that ensure the order of the cell cycle events
-
16. Hartwell LH, Weinert TA (1989) Checkpoints: controls that ensure the order of the cell cycle events. Science 246: 629
-
(1989)
Science
, vol.246
, pp. 629
-
-
Hartwell, L.H.1
Weinert, T.A.2
-
17
-
-
0026318356
-
Participation of p53 protein in the cellular response to DNA damage
-
17. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Graig RW (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51: 6304
-
(1991)
Cancer Res
, vol.51
, pp. 6304
-
-
Kastan, M.B.1
Onyekwere, O.2
Sidransky, D.3
Vogelstein, B.4
Graig, R.W.5
-
19
-
-
0027109075
-
p53, guardian of the genome
-
19. Lane DP (1992) p53, guardian of the genome. Nature 358: 15
-
(1992)
Nature
, vol.358
, pp. 15
-
-
Lane, D.P.1
-
20
-
-
0027285380
-
p53 mutations increase resistance to ionizing radiation
-
20. Lee JM, Bernstein A (1993) p53 mutations increase resistance to ionizing radiation. Proc Natl Acad Sci USA 90: 5742
-
(1993)
Proc Natl Acad Sci USA
, vol.90
, pp. 5742
-
-
Lee, J.M.1
Bernstein, A.2
-
21
-
-
0027944206
-
p53 status and the efficacy of cancer therapy in vivo
-
21. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE, Jacks T (1994) p53 status and the efficacy of cancer therapy in vivo. Science 266: 807
-
(1994)
Science
, vol.266
, pp. 807
-
-
Lowe, S.W.1
Bodis, S.2
McClatchey, A.3
Remington, L.4
Ruley, H.E.5
Fisher, D.E.6
Housman, D.E.7
Jacks, T.8
-
22
-
-
0000540947
-
Surprising pharmacokinetics of UCN-01 in patients with refractory neoplasms may be due to high degree of protein binding
-
22. Lush RM, Senderowicz A, Figg WD, Headlee D, Inoue K, Sausville EA (1997) Surprising pharmacokinetics of UCN-01 in patients with refractory neoplasms may be due to high degree of protein binding. Proc Am Assoc Cancer Res 38: 4029
-
(1997)
Proc Am Assoc Cancer Res
, vol.38
, pp. 4029
-
-
Lush, R.M.1
Senderowicz, A.2
Figg, W.D.3
Headlee, D.4
Inoue, K.5
Sausville, E.A.6
-
23
-
-
0000402751
-
Synergistic interactions between UCN-01 and various anti-cancer agents in vitro: Relationship to p53 function
-
23. Monks A, Vaigro-Wolf A, Hose C, Sausville EA, O'Connor PM (1997) Synergistic interactions between UCN-01 and various anti-cancer agents in vitro: relationship to p53 function. Proc Am Assoc Cancer Res 38: 2137
-
(1997)
Proc Am Assoc Cancer Res
, vol.38
, pp. 2137
-
-
Monks, A.1
Vaigro-Wolf, A.2
Hose, C.3
Sausville, E.A.4
O'Connor, P.M.5
-
24
-
-
0025933514
-
S-phase population analysis does not correlate with the cytotoxicity of camptothecin and 10,11-methyldioxycamptothecin in human colon carcinoma HT-29 cells
-
24. O'Connor PM, Nieves-Neira W, Kerrigan D, Bertrand R, et al (1991) S-phase population analysis does not correlate with the cytotoxicity of camptothecin and 10,11-methyldioxycamptothecin in human colon carcinoma HT-29 cells. Cancer Commun 3: 233
-
(1991)
Cancer Commun
, vol.3
, pp. 233
-
-
O'Connor, P.M.1
Nieves-Neira, W.2
Kerrigan, D.3
Bertrand, R.4
-
25
-
-
0029286242
-
Cyclins, cdks and cancer
-
25. Pines J (1995) Cyclins, cdks and cancer. Semin Cancer Biol 6: 63
-
(1995)
Semin Cancer Biol
, vol.6
, pp. 63
-
-
Pines, J.1
-
26
-
-
0028936626
-
2 delay
-
2 delay. Cancer Res 55: 1643
-
(1995)
Cancer Res
, vol.55
, pp. 1643
-
-
Powell, S.N.1
DeFrank, J.S.2
Connell, P.3
Eogan, M.4
Preffer, F.5
Dombkowski, D.6
Tang, W.7
Friend, S.8
-
27
-
-
0024573538
-
The cdc2 kinase is a nuclear protein that is essential for mitosis in mammalian cells
-
27. Raibowol K, Draetta G, Brizuela L, Vandre D, Beach D (1989) The cdc2 kinase is a nuclear protein that is essential for mitosis in mammalian cells. Cell 57: 393
-
(1989)
Cell
, vol.57
, pp. 393
-
-
Raibowol, K.1
Draetta, G.2
Brizuela, L.3
Vandre, D.4
Beach, D.5
-
29
-
-
0025812689
-
Camptothecin cytotoxicity in mammalian cells is associated with the interaction of persistent double strand breaks in replicating DNA
-
29. Ryan AJ, Squires S, Strutt HL, Johnson RT (1991) Camptothecin cytotoxicity in mammalian cells is associated with the interaction of persistent double strand breaks in replicating DNA. Nucleic Acids Res 19: 3295
-
(1991)
Nucleic Acids Res
, vol.19
, pp. 3295
-
-
Ryan, A.J.1
Squires, S.2
Strutt, H.L.3
Johnson, R.T.4
-
30
-
-
0027157590
-
Cell cycle arrest and growth inhibition by the protein kinase antagonist UCN-01 in human breast carcinoma cells
-
30. Seynaeve CM, Stetler-Stevenson M, Sebers S, Kaur G, Sausville EA, Worland JP (1993) Cell cycle arrest and growth inhibition by the protein kinase antagonist UCN-01 in human breast carcinoma cells. Cancer Res 53: 2081
-
(1993)
Cancer Res
, vol.53
, pp. 2081
-
-
Seynaeve, C.M.1
Stetler-Stevenson, M.2
Sebers, S.3
Kaur, G.4
Sausville, E.A.5
Worland, J.P.6
-
31
-
-
0028878831
-
Topoisomerase I inhibitors: A review of their therapeutic potential in cancer
-
31. Sinha BK (1995) Topoisomerase I inhibitors: a review of their therapeutic potential in cancer. Drugs 49: 11
-
(1995)
Drugs
, vol.49
, pp. 11
-
-
Sinha, B.K.1
-
33
-
-
0025922083
-
cdc2/cyclin B complex in vitro by human cdc25 protein
-
cdc2/cyclin B complex in vitro by human cdc25 protein. Nature 351: 242
-
(1991)
Nature
, vol.351
, pp. 242
-
-
Strausfeld, V.1
-
34
-
-
0023552288
-
UCN-01, a selective inhibitor of protein kinase C from Streptomyces
-
34. Takahashi I, Kobayashi E, Asano K, Yoshida M, Nakano H (1987) UCN-01, a selective inhibitor of protein kinase C from Streptomyces. J Antibiot 40: 1782
-
(1987)
J Antibiot
, vol.40
, pp. 1782
-
-
Takahashi, I.1
Kobayashi, E.2
Asano, K.3
Yoshida, M.4
Nakano, H.5
-
36
-
-
0028990479
-
Apoptosis in 7-hydroxystaurosporine-treated T lymphoblasts correlates with activation of cyclin-dependent kinase 1 and 2
-
36. Wang Q, Worland PJ, Clark JL, Carlson BA, Sausville EA (1995) Apoptosis in 7-hydroxystaurosporine-treated T lymphoblasts correlates with activation of cyclin-dependent kinase 1 and 2. Cell Growth Differ 6: 927
-
(1995)
Cell Growth Differ
, vol.6
, pp. 927
-
-
Wang, Q.1
Worland, P.J.2
Clark, J.L.3
Carlson, B.A.4
Sausville, E.A.5
-
38
-
-
0031007155
-
Down-regulation of DNA replication in extracts of camptothecin-treated cells: Activation of an S-phase checkpoint
-
38. Wang Y, Perrault AR, Iliakis G (1997) Down-regulation of DNA replication in extracts of camptothecin-treated cells: activation of an S-phase checkpoint. Cancer Res 57: 1654
-
(1997)
Cancer Res
, vol.57
, pp. 1654
-
-
Wang, Y.1
Perrault, A.R.2
Iliakis, G.3
|